ATI PHYSICAL THERAPY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.27 USD | +2.15% |
|
+5.96% | -30.46% |
| Mar. 15 | ATI Physical Therapy, Inc. Announces Management Changes, Effective March 28, 2024 | CI |
| Feb. 26 | ATI Physical Therapy, Inc. Provides Revenue Guidance for the First Quarter of 2024 | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 462.7 | 668.7 | 63.21 | 25.84 | 17.98 | - |
| Enterprise Value (EV) 1 | 462.7 | 668.7 | 511.7 | 25.84 | 17.98 | 17.98 |
| P/E ratio | -1,073 x | -0.72 x | -0.12 x | -0.19 x | -0.29 x | -0.34 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.78 x | 1.07 x | 0.1 x | 0.04 x | 0.03 x | 0.02 x |
| EV / Revenue | 0.78 x | 1.07 x | 0.1 x | 0.04 x | 0.03 x | 0.02 x |
| EV / EBITDA | - | 16.8 x | 9.42 x | 0.71 x | 0.39 x | 0.32 x |
| EV / FCF | - | - | -0.67 x | -0.87 x | -0.73 x | -0.96 x |
| FCF Yield | - | - | -148% | -115% | -137% | -105% |
| Price to Book | - | - | 1.36 x | - | - | - |
| Nbr of stocks (in thousands) | 863 | 3,945 | 4,145 | 4,209 | 4,210 | - |
| Reference price 2 | 536.5 | 169.5 | 15.25 | 6.140 | 4.270 | 4.270 |
| Announcement Date | 3/12/21 | 2/25/22 | 3/16/23 | 2/26/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 592.3 | 627.9 | 635.7 | 699 | 718 | 762.3 |
| EBITDA 1 | - | 39.77 | 6.712 | 36.23 | 45.97 | 55.43 |
| EBIT 1 | - | -980 | -539.7 | -27.52 | 5.215 | 13.96 |
| Operating Margin | - | -156.09% | -84.91% | -3.94% | 0.73% | 1.83% |
| Earnings before Tax (EBT) 1 | - | -853 | -541.6 | -63.51 | -51.55 | -42.81 |
| Net income 1 | - | -782 | -493 | -132 | -55.56 | -47.15 |
| Net margin | - | -124.55% | -77.56% | -18.88% | -7.74% | -6.18% |
| EPS 2 | -0.5000 | -234.5 | -125.5 | -31.93 | -14.58 | -12.52 |
| Free Cash Flow 1 | - | - | -93.66 | -29.69 | -24.62 | -18.8 |
| FCF margin | - | - | -14.73% | -4.25% | -3.43% | -2.47% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/12/21 | 2/25/22 | 3/16/23 | 2/26/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 159 | 155.8 | 153.8 | 163.3 | 156.8 | 161.8 | 166.9 | 172.3 | 177.5 | 182.3 | 173.7 | 179.8 | 179.8 | 184.7 | 177.5 |
| EBITDA 1 | 8.539 | 1.643 | -4.695 | 5.436 | -0.392 | 6.363 | 4.79 | 9.338 | 9.429 | 12.68 | 8.538 | 13.01 | 10.38 | 14.05 | 11.9 |
| EBIT 1 | -509.3 | -12.11 | -176.1 | -139.9 | -119.7 | -104.1 | -11.37 | -12.36 | -0.764 | -3.024 | -1.67 | 2.576 | 0.122 | 4.188 | 0.2 |
| Operating Margin | -320.26% | -7.78% | -114.47% | -85.64% | -76.32% | -64.38% | -6.81% | -7.17% | -0.43% | -1.66% | -0.96% | 1.43% | 0.07% | 2.27% | 0.11% |
| Earnings before Tax (EBT) 1 | -354.5 | -3.691 | -161.5 | -148.8 | -123.9 | -107.4 | -25.15 | -21.66 | -14.48 | -2.222 | -15.96 | -11.6 | -13.87 | -10.11 | -14.8 |
| Net income 1 | -325.7 | 8.736 | -137.8 | -135.5 | -116.7 | -102.4 | -26.27 | -22.7 | -18.34 | -8.944 | -17.16 | -12.58 | -14.71 | -11.11 | -14.9 |
| Net margin | -204.8% | 5.61% | -89.55% | -83.01% | -74.43% | -63.31% | -15.74% | -13.17% | -10.34% | -4.91% | -9.88% | -7% | -8.18% | -6.02% | -8.39% |
| EPS 2 | -84.00 | 19.00 | -35.00 | -33.24 | -30.00 | -26.50 | -7.500 | -5.508 | -4.420 | -2.150 | -4.435 | -3.325 | -3.840 | -2.965 | -3.580 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/9/21 | 2/25/22 | 5/9/22 | 8/8/22 | 11/7/22 | 3/16/23 | 5/8/23 | 8/7/23 | 11/6/23 | 2/26/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | 448 | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | 66.81 x | - | - | - |
| Free Cash Flow 1 | - | - | -93.7 | -29.7 | -24.6 | -18.8 |
| ROE (net income / shareholders' equity) | - | -7.63% | -180% | - | - | - |
| ROA (Net income/ Total Assets) | - | - | -37.3% | - | - | - |
| Assets 1 | - | - | 1,321 | - | - | - |
| Book Value Per Share | - | - | 11.20 | - | - | - |
| Cash Flow per Share | - | - | -16.70 | - | - | - |
| Capex 1 | - | - | 28.1 | 17.3 | 17.4 | 17.7 |
| Capex / Sales | - | - | 4.43% | 2.48% | 2.43% | 2.32% |
| Announcement Date | 3/12/21 | 2/25/22 | 3/16/23 | 2/26/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
4.27
USD
Average target price
7
USD
Spread / Average Target
+63.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -30.46% | 17.98M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- ATIP Stock
- Financials ATI Physical Therapy, Inc.
